1. Home
  2. DAWN vs POOL Comparison

DAWN vs POOL Comparison

Compare DAWN & POOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • POOL
  • Stock Information
  • Founded
  • DAWN 2018
  • POOL 1993
  • Country
  • DAWN United States
  • POOL United States
  • Employees
  • DAWN N/A
  • POOL N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • POOL Industrial Specialties
  • Sector
  • DAWN Health Care
  • POOL Consumer Discretionary
  • Exchange
  • DAWN Nasdaq
  • POOL Nasdaq
  • Market Cap
  • DAWN 1.3B
  • POOL 13.8B
  • IPO Year
  • DAWN 2021
  • POOL 1995
  • Fundamental
  • Price
  • DAWN $12.79
  • POOL $349.04
  • Analyst Decision
  • DAWN Strong Buy
  • POOL Hold
  • Analyst Count
  • DAWN 7
  • POOL 8
  • Target Price
  • DAWN $36.17
  • POOL $369.25
  • AVG Volume (30 Days)
  • DAWN 937.9K
  • POOL 339.0K
  • Earning Date
  • DAWN 10-30-2024
  • POOL 02-20-2025
  • Dividend Yield
  • DAWN N/A
  • POOL 1.38%
  • EPS Growth
  • DAWN N/A
  • POOL N/A
  • EPS
  • DAWN N/A
  • POOL 11.61
  • Revenue
  • DAWN $101,953,000.00
  • POOL $5,326,524,000.00
  • Revenue This Year
  • DAWN N/A
  • POOL N/A
  • Revenue Next Year
  • DAWN $36.10
  • POOL $3.90
  • P/E Ratio
  • DAWN N/A
  • POOL $30.06
  • Revenue Growth
  • DAWN N/A
  • POOL N/A
  • 52 Week Low
  • DAWN $11.94
  • POOL $293.51
  • 52 Week High
  • DAWN $18.07
  • POOL $422.73
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 39.97
  • POOL 38.15
  • Support Level
  • DAWN $12.26
  • POOL $340.00
  • Resistance Level
  • DAWN $12.81
  • POOL $380.82
  • Average True Range (ATR)
  • DAWN 0.52
  • POOL 8.16
  • MACD
  • DAWN -0.05
  • POOL -3.71
  • Stochastic Oscillator
  • DAWN 28.94
  • POOL 22.15

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. It sells national-brand and private-label products to approximately 120000 customers. The products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

Share on Social Networks: